At INTERPHEX NYC, L.B. Bohle to Showcase US Debut of Pharma Market's First Wet Granulator with Integrated, Truly Continuous Dryer

Warminster, PA – L.B. Bohle, a longstanding manufacturer and supplier of high-quality processing solutions for pharmaceutical solids, will showcase a first-of-its-kind truly continuous granulator and dryer at INTERPHEX NYC, April 1-3. At Booth 1519A, the company will offer technical overviews of its QbCon®1, a three-in-one module providing continuous raw material dosing, twin-screw wet granulation and […]

Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis

Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat life-threatening pulmonary diseases, today announce the initiation of a strategic partnership in progressive pulmonary fibrosis, commencing with the ongoing MIST study, a Phase 2b clinical trial evaluating the safety and efficacy of AP01 (inhaled pirfenidone) in patients with progressive pulmonary fibrosis (PPF). New partnership marks […]

Cosmo and Glenmark Announce UK MHRA Approval of Winlevi for Treatment of Acne

Dublin, Ireland and Mumbai, India | London, U.K: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Glenmark Pharmaceuticals Limited (Glenmark), a global research-led pharmaceutical company, today announced that Glenmark had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi® in the United Kingdom. Winlevi® is a topical treatment for […]

The Future of Drug Discovery

The landscape of drug discovery is evolving rapidly, driven by the need for innovative solutions to tackle complex diseases. Traditional R&D models, characterized by internal research silos, have increasingly shown limitations in addressing the complexities of modern biomedical challenges. The future, it seems, lies not in isolated efforts but in co-creation, where collaboration and the […]

Why Early Intervention Is Key To Managing Chronic Health Concerns

Proactive health management is essential for maintaining a good quality of life, particularly when it comes to chronic health conditions. Early intervention plays a significant role in preventing complications and improving outcomes for individuals facing these persistent issues. Understanding the importance of timely action can empower patients and caregivers alike. The Importance of Early Detection […]

McKesson Acquires Controlling Stake in PRISM Vision

McKesson Corporation has announced its agreement to acquire a controlling 80% interest in PRISM Vision Holdings, LLC, investing approximately $850 million to expand its leadership in retina and ophthalmology care. PRISM Vision, a leading provider of general ophthalmology and retina management services, will see its physicians retain the remaining 20% interest. “The acquisition of PRISM […]

Thermo Fisher Launches Adolescent Alopecia Areata Registry

Thermo Fisher Scientific Inc., the global leader in serving science, has announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry. This initiative addresses a significant unmet need for real-world, adolescent-specific data on alopecia areata, an autoimmune disease that causes patchy or complete hair loss on the scalp and other parts of the […]

Thermo Fisher Partners with X-ELIO for Renewable Energy

Thermo Fisher Scientific has taken a significant step toward achieving its sustainability goals by signing a 10-year virtual power purchase agreement (VPPA) with renewable energy developer X-ELIO. This agreement supports the Lorca solar project, which is set to become operational in 2026 and aims to increase access to renewable electricity for Thermo Fisher and its […]

New Data Shows Gazyva's Superiority in Lupus Nephritis

The New England Journal of Medicine has published detailed findings from Roche’s Phase III REGENCY trial, which demonstrated the superiority of Gazyva®/Gazyvaro® (obinutuzumab) in combination with standard therapy for treating active lupus nephritis (LN). The trial shows a compelling improvement in the complete renal response (CRR) rate, with nearly half of the patients achieving CRR […]

FDA Approves Roche’s Susvimo for Diabetic Macular Edema

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL as the first and only continuous delivery treatment for diabetic macular edema (DME), a leading cause of vision loss in adults with diabetes. This groundbreaking approval provides a less burdensome alternative to standard-of-care eye injections, which often […]